# Diclofenac vs. Placebo in a Randomized Double Blind Controlled Trial in Post ERCP Pancreatitis

> **NCT01946984** · PHASE1 · COMPLETED · sponsor: **Specialized Arab Hospital** · enrollment: 182 (actual)

## Conditions studied

- Post-ERCP Acute Pancreatitis.

## Interventions

- **PROCEDURE:** ERCP
- **DRUG:** Diclofenac hydroxyethylpyrrolidine
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT01946984
- **Lead sponsor:** Specialized Arab Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2013-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01946984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01946984, "Diclofenac vs. Placebo in a Randomized Double Blind Controlled Trial in Post ERCP Pancreatitis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01946984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*